LINDSAY MONTGOMERY: Open Payments
NPI 1750692489 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,376 in 66 payments from 25 companies in 2025. Trend: 2023 $937 · 2024 $1,050 · 2025 $1,376
Food & beverage: $1,276Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $188 |
| Pharmacosmos Therapeutics Inc. | 6 | $115 |
| Daiichi Sankyo Inc. | 6 | $106 |
| GlaxoSmithKline, LLC. | 4 | $104 |
| Novartis Pharmaceuticals Corporation | 5 | $97 |
| ABBVIE INC. | 5 | $95 |
| Incyte Corporation | 4 | $83 |
| Genmab U.S., Inc. | 3 | $74 |
| Merck Sharp & Dohme LLC | 3 | $66 |
| Celltrion USA Inc. | 2 | $49 |
Products named: MONOFERRIC, DARZALEX, ZEJULA, VENCLEXTA, KEYTRUDA, Enhertu, RYBREVANT, KISQALI.
Industry payments across KY — which companies pay providers there.
